Evidence map›Paper›PMID 35758259›Full record

ArticleClinical and experimental immunology2022

6-Sulfo LacNAc monocytes are quantitatively and functionally disturbed in systemic sclerosis patients.

Laure Ricard, Déborah Eshagh, Lama Siblany, Frédéric de Vassoigne, Florent Malard, Charlotte Laurent, Pauline Beurier, Vincent Jachiet, Sébastien Rivière, Olivier Fain and 3 more

Open access · bronzeAbstract readComment
In one paragraph

Article in Clinical and experimental immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Laure RicardSorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.ORCID 0000-0003-4416-3285
Déborah EshaghSorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
Lama SiblanySorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
Frédéric de VassoigneSorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
Florent MalardSorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
Charlotte LaurentSorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
Pauline BeurierSorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
Vincent JachietSorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
Sébastien RivièreAP-HP, Hôpital Saint-Antoine, Service de Médecine Interne et de l'Inflammation-(DHU i2B), Paris, France.
Olivier FainAP-HP, Hôpital Saint-Antoine, Service de Médecine Interne et de l'Inflammation-(DHU i2B), Paris, France.
Mohamad MohtySorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
Béatrice GauglerSorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.
Arsène MekinianSorbonne Université, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France.ORCID 0000-0003-2849-3049
Inserm · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis, microangiopathy, and autoantibodies. We previously reported that circulating follicular helper T (cTfh) cells are increased in SSc and induce plasmablast differentiation. However, mechanisms leading to cTfh cell expansion and activation in SSc remain to be established. Tfh cells require IL-12 for their expansion and differentiation. 6-Sulfo LacNAc monocytes (slanMo), a subset of monocytes, have a higher capacity to produce IL-12 and to induce CD4+ T cell proliferation in comparison with dendritic cells (DC) or classical monocytes. The aim of this study was to perform a quantitative and functional analysis of monocytes and DC and to correlate them with cTfh cell expansion and clinical manifestations in SSc. Using flow cytometry, we analyzed different monocyte subsets including slanMo and DC from 36 SSc patients and 26 healthy controls (HC). In vitro culture experiments of sorted slanMo were performed for functional analysis and cytokine production. We observed that slanMo, intermediate and non-classical monocytes were increased in SSc in comparison with HC. Furthermore, the increase in slanMo cells was more potent in patients with diffuse SSc. We observed a significant positive correlation between slanMo and cTfh cell levels in SSc patients but not in HC. Other monocyte subsets did not correlate with cTfh cell expansion. In addition, we observed that in vitro, slanMo cells from SSc patients produced less IL-12 than slanMo from HC. SlanMo are increased in SSc and may participate in the activation of cTfh cells in SSc.

Indexed as

MonocytesScleroderma, SystemicHormonesHumansInterleukin-12T-Lymphocytes, Helper-InducerHormonesInterleukin-126follicular helper T cellsLacNAc monocytessulfosystemic sclerosis

Identifiers

PMID35758259
PMCPMC9390843
OpenAlexW4283588682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.